The pharmaceutical grade dimethyl sulfoxide market is driven substantially by massive growth in the pharmaceutical and healthcare industries. The compound has widespread uses in the treatment of chronic conditions such as arthritis, inflammation, cancer, and the side effects of chemotherapy. It is easily absorbed by membranes such as the skin and is thus optimal for use in certain topical creams and drugs. It is also helpful in treating interstitial cystitis, a chronic bladder condition. These widespread pharmacological uses are driving demand in the sector.
Despite this, the strict production regulations around the pharmaceutical grade compound and an intricate manufacturing process serve as barriers to growth in the market. However, the massive expansion of the pharmaceutical sector and the development of new innovative drugs for the treatment of chronic illnesses and topical conditions is set to drive future growth in the sector.